Ofir Meir - אופיר מאיר

Ofir Meir has a diverse work experience in the field of biotechnology and crop protection. Ofir worked as the CTO at Tropic starting in 2017. Prior to that, they were the Biotechnology Crop Protection R&D Director at Evogene from 2016 to 2017. In this role, they were responsible for formulating and directing research plans, leading scientific teams, and managing project delivery. Before joining Evogene, Ofir worked at Monsanto from 2013 to 2016, where they held the positions of In vivo Discovery Lead and Discovery Lead. Their responsibilities included developing innovative production systems, leading research teams, managing budgets, and reporting to stakeholders. Earlier in their career, Ofir worked at Rosetta Green Ltd. as the Head of Agro Chemistry Division and Team Leader, where they gained experience in inventing new technologies and successfully selling ideas to multinational agricultural companies. Ofir also worked as an Intern at the Weizmann Institute of Science, where they set up a system/platform for gene therapy experiments, and as a Postdoc at the Weizmann Institute of Science, conducting research on resistant tumor cells. Overall, Ofir Meir's work experience demonstrates their expertise in research and development, team leadership, and technology commercialization in the biotechnology industry.

Ofir Meir's education history includes a PhD in Life Science from the Feinberg Graduate School of the Weizmann Institute of Science, which they obtained from 2005 to 2010. Prior to that, they also pursued a PhD in Life Science from the same institution, completing it from 2005 to 2009. Ofir obtained another PhD in Biology from the Weizmann Institute from 2005 to 2009 as well. Before their doctoral studies, Ofir Meir attended The Hebrew University of Jerusalem from 1999 to 2005, where they conducted a study on the Mechanism of Post Transcriptional Gene Silencing in tobacco plants. The specific degree earned during this period is not provided.